A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues
Posted in Partners achievements on 03.09.2018
In our ageing society, there is a huge medical need for therapies against degenerative muscle and tendon diseases. This study by researchers from ZHAW and Novartis Institutes for Biomedical Research describes a novel drug screening platform with automated production of 3D musculoskeletal-tendon-like tissues, representing a promising tool to address musculoskeletal diseases. Cells and bioink were printed using the 3DDiscovery™ bioprinter, in dumbbell lines designed by regenHU’s integrated BioCAD™ program.